ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

2.715
0.055
( 2.07% )
Updated: 13:36:28

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.715
Bid
2.71
Ask
2.72
Volume
95,645
2.64 Day's Range 2.725
1.25 52 Week Range 32.415
Market Cap
Previous Close
2.66
Open
2.66
Last Trade
15
@
2.715
Last Trade Time
13:36:28
Financial Volume
$ 257,942
VWAP
2.6969
Average Volume (3m)
786,172
Shares Outstanding
28,874,513
Dividend Yield
-
PE Ratio
-1.04
Earnings Per Share (EPS)
-2.62
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $2.66. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 1.25 to $ 32.415.

Aerovate Therapeutics currently has 28,874,513 shares outstanding. The market capitalization of Aerovate Therapeutics is $76.81 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -1.04.

AVTE Latest News

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024 NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Jade Biosciences...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1455.64202334632.572.7152.523257172.60882053CS
40.61529.28571428572.132.0718826442.49693626CS
120.86546.75675675681.8531.8157861722.41864234CS
26-16.905-86.162079510719.6225.2851.259484842.71675112CS
52-12.045-81.605691056914.7632.4151.255462474.95700108CS
156-11.565-80.98739495814.2832.4151.252403938.01280992CS
260-25.285-90.30357142862832.4151.252280768.67097821CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QMCOQuantum Corporation
$ 18.88
(106.79%)
25.5M
ZENAZenaTech Inc
$ 3.28
(83.24%)
26.78M
RGTIRigetti Computing Inc
$ 2.755
(58.33%)
238.48M
XCURExicure Inc
$ 28.65
(55.88%)
2.1M
VSTEVast Renewable Ltd
$ 2.4672
(49.53%)
38.04M
SAVACassava Sciences Inc
$ 4.7001
(-82.25%)
76.81M
ONCTOncternal Therapeutics Inc
$ 0.6201
(-45.61%)
548.67k
CRKNCrown Electrokinetics Corporation
$ 0.45415
(-30.94%)
7.74M
AMPGAmplitech Group Inc
$ 0.9395
(-24.23%)
594.91k
NNENano Nuclear Energy Inc
$ 25.89
(-22.95%)
10.43M
RGTIRigetti Computing Inc
$ 2.755
(58.33%)
241.26M
ELABElevai Labs Inc
$ 0.0163
(-18.91%)
233.23M
NVDANVIDIA Corporation
$ 137.10
(-3.42%)
180.17M
SMCISuper Micro Computer Inc
$ 36.95
(11.46%)
126.3M
CTXRCitius Pharmaceuticals Inc
$ 0.1468
(9.72%)
125.26M

Your Recent History

Delayed Upgrade Clock